Brox v. Wood's Hole, Martha's Vineyard and Nantucket Steamship Authority

CourtDistrict Court, D. Massachusetts
DecidedDecember 11, 2023
Docket1:22-cv-10242
StatusUnknown

This text of Brox v. Wood's Hole, Martha's Vineyard and Nantucket Steamship Authority (Brox v. Wood's Hole, Martha's Vineyard and Nantucket Steamship Authority) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brox v. Wood's Hole, Martha's Vineyard and Nantucket Steamship Authority, (D. Mass. 2023).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

CIVIL ACTION NO. 22-10242-RGS

CAPTAIN ALBERT BROX et al.

v.

THE WOODS HOLE, MARTHA’S VINEYARD, AND NANTUCKET STEAMSHIP AUTHORITY and JANICE KENNEFICK

MEMORANDUM AND ORDER ON PLAINTIFFS’ RENEWED MOTION FOR PRELIMINARY INJUNCTIVE RELIEF

December 11, 2023

STEARNS, D.J.

Plaintiffs, who are eleven current and former employees of the Woods Hole, Martha’s Vineyard, and Nantucket Steamship Authority (Authority), claim that the Authority infringed on their constitutional and statutory rights by implementing a policy (Policy) requiring that they be vaccinated against COVID-19 to maintain their employee status at the Authority unless qualified for a medical or religious exemption. Plaintiffs each submitted requests to be exempt from the Policy on religious grounds. The Authority denied each of their requests.1 Plaintiffs claim that the Policy violates their right to free exercise of religious worship under Article 2 of the Massachusetts

Declaration of Rights (Count I); the First Amendment’s Free Exercise Clause (Count II); the Massachusetts Unlawful Discrimination Law, Mass. Gen. Laws ch. 151B, § 4 (Count III); and their Fourteenth Amendment due process rights to privacy, personal autonomy, and personal identity (Count IV). They

seek preliminary injunctive relief from enforcement of the Policy. Plaintiffs first moved for a preliminary injunction on February 18, 2022. The court denied the motion on March 10, 2022, and plaintiffs timely

appealed on April 7, 2022. On October 6, 2023, the First Circuit affirmed the court’s denial of preliminary injunctive relief as to Counts I, III, and IV and vacated the court’s denial as to Count II, directing the court to consider the appropriate level of scrutiny to apply to plaintiffs’ free exercise claims

and to determine “how [the First Circuit’s] decisions in Mills and Lowe bear on appellants’ request for such relief.” Brox v. Woods Hole, Martha’s Vineyard & Nantucket Steamship Auth., 83 F.4th 87, 100 (1st Cir. 2023). After careful consideration of the parties’ initial and renewed briefing and

1 Four plaintiffs subsequently agreed to be vaccinated and remained employed by the Authority. Seven plaintiffs refused vaccination and were terminated. the impact of Mills and Lowe on plaintiffs’ claims, the court will DENY plaintiffs’ renewed motion for preliminary injunctive relief.

BACKGROUND COVID-19 Pandemic2 The COVID-19 pandemic is among the deadliest pandemics in human history. The disease spread rapidly throughout the world and to date has

killed over one million Americans, including 25,000 Massachusetts residents. To combat the spread of the virus, the United States Food and Drug Administration (FDA) granted emergency use authorizations (EUAs)

to COVID-19 vaccines manufactured by Pfizer/BioNTech (Pfizer Vaccine) and Moderna (Moderna Vaccine) in December of 2020 and to a vaccine manufactured by Janssen Biotech, Inc. (Janssen Vaccine) in February of 2021.3

2 The court draws much of this background from the websites of the Center for Disease Control and Prevention (CDC) and the United States Food and Drug Administration (FDA). Because the accuracy of this information “cannot reasonably be questioned,” the court may take judicial notice of these facts. Fed. R. Evid. 201(b)(2); see also Pietrangelo v. Sununu, 2021 WL 4487850, at *1 n.1 (1st Cir. Oct. 1, 2021) (taking judicial notice of “state and federal vaccine distribution data” at preliminary injunction stage); Gent v. CUNA Mut. Ins. Soc’y, 611 F.3d 79, 84 n.5 (1st Cir. 2010) (taking judicial notice of information on CDC’s website).

3 See Press Release, U.S. FDA, FDA Approves First COVID-19 Vaccine (Aug. 23, 2021), https://www.fda.gov/news-events/press-announcements/ fda-approves-first-covid-19-vaccine (Pfizer Press Release); Press Release, Before granting full approval of the Pfizer and Moderna Vaccines, the FDA reviewed “hundreds of thousands of pages” of data and conducted

independent analyses of the Vaccines’ safety and effectiveness.4 The FDA concluded that the Pfizer and Moderna Vaccines met its “high standards for safety, effectiveness, and manufacturing quality” and gave full approval to the Pfizer Vaccine on August 23, 2021, and to the Moderna Vaccine on

January 31, 2022.5 The Vaccines are extremely effective.6 But, as is common with vaccines, the immunity generated by the Vaccines wanes over time.

Accordingly, in September of 2021, the FDA approved “booster” doses of the

U.S. FDA, Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine (Jan. 31, 2022), https://www.fda.gov/news-events/press-announcements/coronavirus- covid-19-update-fda-takes-key-action-approving-second-covid-19-vaccine (Moderna Press Release); 86 Fed. Reg. 28608 (May 27, 2021).

At Janssen’s request, the FDA revoked the EUA for the Janssen vaccine on June 1, 2023. Jannsen COVID-19 Vaccine, U.S. FDA, https://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber- regulated-biologics/janssen-covid-19-vaccine (last updated June 2, 2023).

4 Pfizer Press Release (emphasis omitted); see also Moderna Press Release.

5 Moderna Press Release (emphasis omitted); see also Pfizer Press Release.

6 See COVID-19 Vaccine Effectiveness Update, CDC (Aug. 31, 2023), https://covid.cdc.gov/covid-data-tracker/#vaccine-effectiveness. Pfizer and Moderna Vaccines, and it has since approved additional booster doses.7 Although the CDC encourages vaccinated individuals to receive

booster doses to bolster their immunity, it considers individuals fully vaccinated if they received the initial two-dose series of the Pfizer or Moderna Vaccine or one dose of a single-dose COVID-19 vaccine, such as the Janssen Vaccine.8 Since the advent of the widespread use of the Vaccines,

COVID-19 infections and deaths have decreased significantly. The Policy The Authority, which the Massachusetts Legislature created in 1960 to

provide ferry service to the islands of Martha’s Vineyard and Nantucket, “serves members from all walks of life, including young children, elderly individuals and the immunocompromised.” Decl. of Janice Kennefick in Opp’n to Pls.’ Mot. for a Prelim. Inj. (Kennefick Decl.) (Dkt. # 16) ¶¶ 3-5, 11.

Many of the Authority’s 750 employees, including plaintiffs, “regularly

7 See Press Release, U.S. FDA, FDA Authorizes Booster Dose of Pfizer- BioNTech COVID-19 Vaccine for Certain Populations (Sept. 22, 2021), https://www.fda.gov/news-events/press-announcements/fda-authorizes- booster-dose-pfizer-biontech-covid-19-vaccine-certain-populations.

8 Data Definitions for COVID-19 Vaccinations in the United States, CDC, https://www.cdc.gov/coronavirus/2019-ncov/vaccines/reporting- vaccinations.html (last updated Oct. 13, 2023). interact with fellow employees, customers and/or vendors as part of their job responsibilities.” Id. ¶ 20.

On January 3, 2022, the Authority notified employees of the Policy.9 Id. ¶ 27. The Policy was created “to prevent viral infection and transmission,”10 and it required all employees to “receive[] at least one COVID-19 vaccination by . . . January 5, 2022” and to be “fully vaccinated in

accordance with the CDC definition on or before February 16, 2022.” Id., Ex. F (Policy) at 1-2 (emphasis omitted). The Policy permitted two types of exemptions: First, if an employee provided documentation from a healthcare

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Irwin v. Dixion
50 U.S. 10 (Supreme Court, 1850)
Rizzo v. Goode
423 U.S. 362 (Supreme Court, 1976)
McDaniel v. Paty
435 U.S. 618 (Supreme Court, 1978)
Gent v. CUNA Mutual Insurance Society
611 F.3d 79 (First Circuit, 2010)
Esso Standard Oil Co. v. Monroig-Zayas
445 F.3d 13 (First Circuit, 2006)
Marketa Wills v. Brown University
184 F.3d 20 (First Circuit, 1999)
Noonan v. Wonderland Greyhound Park Realty LLC
723 F. Supp. 2d 298 (D. Massachusetts, 2010)
Trinity Lutheran Church of Columbia, Inc. v. Comer
582 U.S. 449 (Supreme Court, 2017)
Espinoza v. Montana Dept. of Revenue
591 U.S. 464 (Supreme Court, 2020)
Roman Catholic Diocese of Brooklyn v. Cuomo
592 U.S. 14 (Supreme Court, 2020)
Tandon v. Newsom
593 U.S. 61 (Supreme Court, 2021)
Does v. Mills
16 F.4th 20 (First Circuit, 2021)
Kennedy v. Bremerton School Dist.
597 U.S. 507 (Supreme Court, 2022)
Lowe v. Mills
68 F.4th 706 (First Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Brox v. Wood's Hole, Martha's Vineyard and Nantucket Steamship Authority, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brox-v-woods-hole-marthas-vineyard-and-nantucket-steamship-authority-mad-2023.